Denali Therapeutics Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2018 | — | -4,016.8% | -3,693.9% |
| Jun 2018 | — | -3,481.9% | -3,320.6% |
| Sep 2018 | — | -3,176.9% | -2,959.9% |
| Dec 2018 | — | 59.5% | 61.7% |
| Mar 2019 | — | -1,010.9% | -927.3% |
| Jun 2019 | — | -1,495.4% | -1,390.0% |
| Sep 2019 | — | -368.7% | -340.0% |
| Dec 2019 | — | -1,236.3% | -1,156.4% |
| Mar 2020 | — | -1,663.9% | -1,575.0% |
| Jun 2020 | — | -1,048.0% | -1,004.9% |
| Sep 2020 | — | -640.0% | -619.9% |
| Dec 2020 | — | 77.0% | 77.3% |
| Mar 2021 | — | -898.9% | -884.0% |
| Jun 2021 | — | -269.5% | -264.6% |
| Sep 2021 | — | -1,619.5% | -1,600.5% |
| Dec 2021 | — | -616.3% | -601.4% |
| Mar 2022 | — | -157.8% | -154.8% |
| Jun 2022 | — | -117.0% | -112.0% |
| Sep 2022 | — | -3,020.1% | -2,902.5% |
| Dec 2022 | — | -1,024.4% | -959.6% |
| Mar 2023 | — | -343.8% | -312.4% |
| Jun 2023 | — | 58.0% | 62.3% |
| Sep 2023 | — | -8,981.5% | -7,841.6% |
| Jun 2026 | 97.4% | -3,622.1% | -3,539.2% |